Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press Careers
Contact Us
Company Logo
Reports Store
Top 11 Hot Markets
NEW
 Biologics Hot Titles 2025
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Paper, Plastics, Rubber, Wood And Textile
Medical Equipment Metal And Mineral Mining Oil And Gas Pharmaceuticals Professional Services Recreation Retail And Wholesale
Services Social Services Transport Transport Services Utilities Veterinary Healthcare Electrical And Electronics Media
Mega Trends
3D Printing 5G and 6G Technologies Advanced Analytics and Predictive Analytics Alternative Proteins (Plant-Based, Cultured Meat) Artificial Intelligence (AI) Autonomous Systems Augmented Reality (AR) and Virtual Reality (VR) Big Data Analytics
Blockchain, Cryptocurrencies and Decentralized Finance (DeFi) Biotechnology Cloud Computing Cybersecurity Digital Therapeutics Digitalization E-commerce and Digital Retail Edtech and E-Learning Electric Mobility
ESG (Environmental, Social, Governance) Investments Fintech (Digital Payments, Neobanking, Open Banking) Healthtech and Telehealth Industry 4.0 and 5.0 Internet of Things (IoT) Nanotechnology Precision Medicine and Genomics Quantum Computing
Regtech and Insurtech Robotics Smart Homes and Buildings Space Economy Sustainability Sustainable Consumer Products Wearable Technology
Market Intelligence Platform
About GMM Global Forecast
NEW
 Real Growth Rate Analysis Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal

Global Human Embryonic Stem Cells Report 2025, Forecast To 2034

25 Mar, 2025

What Has Been the Progress and Growth of the Human Embryonic Stem Cells Market in Recent Years?

The human embryonic stem cells market has seen considerable growth due to a variety of factors.
• The human embryonic stem cells market has shown rapid growth in recent years. It is expected to increase from $1.24 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%.
The growth is driven by funding and investments, regulatory approvals, rising public awareness, the development of regenerative medicine, and expanding clinical applications.

How Does the Forecast Look for the Human Embryonic Stem Cells Market?

The human embryonic stem cells market is expected to maintain its strong growth trajectory in upcoming years.
• The human embryonic stem cells market is projected to grow to $2.02 billion by 2029, at a CAGR of 10.1%.
The growth is driven by the increase in cell therapy production facilities, the demand for regenerative therapies, the incidence of cardiac and malignant diseases, and advancements in stem cell biology research. Trends include regenerative medicine, personalized medicine, drug discovery applications, and biobanking expansion.

Gain Insights Into The Human Embryonic Stem Cells Global Market Report 2025 With A Free Sample Report Here:

What Are The Leading Drivers Of Growth In The Human Embryonic Stem Cells Market?

Government funding for regenerative medicine development is expected to drive the growth of the human embryonic stem cells market. Increased government investment in regenerative medicine is due to the growing prevalence of chronic diseases and advancements in stem cell research. In May 2022, Canada’s government allocated $45 million to stem cell and regenerative medicine research, further boosting the sector's growth.

How Are The Segments Defined Within The Global Human Embryonic Stem Cells Market?

The human embryonic stem cells market covered in this report is segmented –
1) By Type: Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells
2) By Product: Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing
3) By Application: Research, Clinical Trials, Other Applications Subsegments:
1) By Totipotent Stem Cells: Embryonic Totipotent Stem Cells, Induced Totipotent Stem Cells
2) By Pluripotent Stem Cells: Human Embryonic Stem Cells (hESCs), Induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cell Lines, Conditioned Pluripotent Stem Cells
3) By Unipotent Stem Cells: Somatic Stem Cells, Adult Stem Cells, Tissue-Specific Stem Cells

Pre-Book The Human Embryonic Stem Cells Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:

What Trends Are Shaping The Human Embryonic Stem Cells Market?

Major corporations in the human embryonic stem cell sector are striving to diversify their therapeutic applications, such as using pluripotent stem cells for Parkinson's disease treatments, to attain a competitive advantage. These pluripotent stem cells are leveraged to create dopaminergic neurons with the intention of substituting missing dopamine-producing neurons and bringing back motor functions. For example, Bayer AG, a pharmaceutical and biotechnology firm based in Germany, set up its first Cell Therapy Manufacturing plant in California in October 2023. An investment of $250 million was made to globally manufacture cell and gene therapies. Initially, this facility will concentrate on producing bemdaneprocel from BlueRock Therapeutics, derived from pluripotent stem cells (PSC) to treat Parkinson's disease. The factory is equipped with fully electric manufacturing to cater to the manufacturing capacity needs of the regenerative medicine field.

Who Are the Key Players In The Human Embryonic Stem Cells Market?

Major companies operating in the human embryonic stem cells market are:
• Thermo Fisher Scientific Inc.
• Takeda Pharmaceutical Company Limited
• Gilead Sciences Inc.
• Merck KgaA
• Astellas Pharma Inc.
• Lonza Group
• PerkinElmer Inc.
• R&D Systems
• LifeCell
• Takara Bio Inc.
• ViaCyte Inc.
• PromoCell GmbH
• CellGenix GmbH
• PeproTech Inc.
• Lineage Cell Therapeutics Inc.
• BioTime
• Asterias Biotherapeutics Inc.
• ESI BIO
• STEMCELL Technologies Inc.
• TATAA Biocenter
• Celgene Corporation

What Is The Most Dominant Region In The Human Embryonic Stem Cells Market?

North America was the largest region in the human embryonic stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human embryonic stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.